Ledger.Open graph →
SEC Form D · filed April 25, 2018

Anelixis Therapeutics, Inc

Offering
$4.5M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Walter C. Ogier · CAMBRIDGE, MADirectorMaeve C. Mcnally · CAMBRIDGE, MAExecAugie Nieto · CAMBRIDGE, MADirectorSteven Perrin · CAMBRIDGE, MAExec · DirectorWalter C. Ogier · Boston, MADirectorAugie Nieto · CAMBRIDGE, MADirectorMaeve C. Mcnally · CAMBRIDGE, MAExecSteven Perrin · CAMBRIDGE, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗